Corrias, Maria V <br/><br/>
Event-free survival of infants and toddlers enrolled in the HR-NBL-1/SIOPEN trial is associated with the level of neuroblastoma mRNAs at diagnosis.  [electronic resource] 

 -  Pediatric blood & cancer  07 2018 
 - e27052 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1545-5017 
<br/><br/><label>Standard No.: </label>10.1002/pbc.27052  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Area Under Curve<br/>Biomarkers, Tumor--analysis<br/>Female<br/>Homeodomain Proteins--analysis<br/>Humans<br/>Infant<br/>Infant, Newborn<br/>Kaplan-Meier Estimate<br/>Male<br/>Neuroblastoma--metabolism<br/>Prognosis<br/>Progression-Free Survival<br/>Proportional Hazards Models<br/>RNA, Messenger--analysis<br/>ROC Curve<br/>Sensitivity and Specificity<br/>Transcription Factors--analysis<br/>Tyrosine 3-Monooxygenase--analysis